FDA NDC Directory · JSON-LD · Markdown

LEQEMBI

NDC 62856-212 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namelecanemab
Labeler / ManufacturerEisai Inc.
Marketing categoryBiologic License Application · App BLA761269
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsLECANEMAB (100 mg/mL)
Marketing started20230106
Package count1

External sources

Source: openFDA. Public-domain (CC0).